GlobalDeal

Anavex Life Sciences

Biotechnology · New York, United States

anavex.com

About Anavex Life Sciences

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurodegenerative diseases, including Alzheimer's disease and other central nervous system disorders. The company's lead product candidate, ANAVEX2-73, is designed to target the underlying mechanisms of these diseases, aiming to improve cognitive function and overall quality of life for patients. Anavex is committed to advancing its research and development efforts through rigorous clinical trials and collaborations with leading research institutions. The company is headquartered in New York, USA, and is publicly traded on the NASDAQ under the ticker symbol AVXL.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Neurodegenerative Diseases, Clinical Trials, Drug Development, Biopharmaceuticals
Location
New York, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2013

Products and services

Open Anavex Life Sciences in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →